Costs of Dementia in Low- And Middle-Income Countries: A Systematic Review

Abstract

Background: The proportion of people living with dementia in low- and middle-income countries (LMICs) is expected to reach 71% by 2050. Appraising the economic burden of the disease may contribute to strategic policy planning. Objective: To review studies conducted on the costs of dementia in LMICs, describe their methodology and summarize available costs estimates. Methods: Systematic review, including a search of health, economics, and social science bibliographic databases. No date or language restrictions were applied. All studies with a direct measure of the costs of dementia care were included. Results: Of the 6,843 publications reviewed, 17 studies from 11 LMICs were included. Costs of dementia tended to increase with the severity of the disease. Medical costs were greater in the mild stage, while social and informal care costs were highest in the moderate and severe stages. Annual cost estimates per patient ranged from PPP$131.0 to PPP$31,188.8 for medical costs; from PPP$16.1 to PPP$10,581.7 for social care services and from PPP$140.0 to PPP$25,798 for informal care. Overall, dementia care can cost from PPP$479.0 to PPP$66,143.6 per year for a single patient. Conclusion: Few studies have been conducted on the costs of dementia in LMICs, and none so far in Africa. There seems to be a need to provide accurate data on the burden of disease in these countries to guide public health policies in the coming decades.

A review of SaiLuoTong (MLC-SLT) development in vascular cognitive impairment and dementia

“…More than two-thirds of people with dementia live in low- and middle-income countries (LMICs) ( Kenne Malaha et al, 2023 ). For VCID, VCI on top of a stroke increases the economic burden and the burden of care, with the healthcare cost of VaD amounting to 23% higher than that of AD ( Wimo and Winblad, 2003 ).…”

The worldwide costs of dementia in 2019

“… 12 Additional studies identified from reference lists were added if they were of good quality. Inputs were gathered from relevant indicators in WHO’s Global Dementia Observatory (GDO), as well as from work by other institutions such as the World Bank (WB), International Monetary Fund (IMF), Organisation for Economic Co-operation and Development (OECD), International Labour Organization (ILO), Institute for Health Metrics and Evaluation (IHME), ADI, Inserm, 13 and the 10/66 Dementia Research Group. 14 …”

Integrative Precision Medicine for Dementia and Alzheimer's Diseases in Africa

“…In the African context, strategies may prioritize clinical assessment, basic laboratory testing, and point-of-care diagnostics as a result of limited resources. Telemedicine and mobile health initiatives are also significant contributors in this context [14] . Many nations frequently utilize sophisticated technology such as artificial intelligence (AI)-assisted diagnostics and genetic testing in conjunction with conventional approaches [15] .…”